Redesca - Enoxaparin Sodium Solution for Injection

RedescaTM is the only heparin biosimilar that is clinically tested, has the largest global patient exposure, and that supprts affordability (health care).

Most popular related searches

intravenous injectable

intravenous injection

clinical testing

subcutaneous injection

injectable solutions

injectable solution

Heparin

PrREDESCA® / PrREDESCA HP®

Enoxaparin sodium solution for injection

Available Strengths
Solution for subcutaneous or intravenous injection, 100 mg/mL

30 mg / 0.3 mL PFS DIN 02509075
40 mg / 0.4 mL PFS DIN 02509083
60 mg / 0.6 mL PFS DIN 02509091
80 mg / 0.8 mL PFS DIN 02509105
100 mg / 1 mL PFS DIN 02509113
300 mg / 3 mL VIAL DIN 02509121

Solution for subcutaneous or intravenous injection, 150 mg/mL (High Potency)

120 mg / 0.8 mL PFS DIN 02509148
150 mg / 1 mL PFS DIN 02509156